Literature DB >> 34915726

Radiogenomics and Artificial Intelligence Approaches Applied to Cardiac Computed Tomography Angiography and Cardiac Magnetic Resonance for Precision Medicine in Coronary Heart Disease: A Systematic Review.

Teresa Infante1, Carlo Cavaliere2, Bruna Punzo2, Vincenzo Grimaldi2, Marco Salvatore2, Claudio Napoli1,2.   

Abstract

The risk of coronary heart disease (CHD) clinical manifestations and patient management is estimated according to risk scores accounting multifactorial risk factors, thus failing to cover the individual cardiovascular risk. Technological improvements in the field of medical imaging, in particular, in cardiac computed tomography angiography and cardiac magnetic resonance protocols, laid the development of radiogenomics. Radiogenomics aims to integrate a huge number of imaging features and molecular profiles to identify optimal radiomic/biomarker signatures. In addition, supervised and unsupervised artificial intelligence algorithms have the potential to combine different layers of data (imaging parameters and features, clinical variables and biomarkers) and elaborate complex and specific CHD risk models allowing more accurate diagnosis and reliable prognosis prediction. Literature from the past 5 years was systematically collected from PubMed and Scopus databases, and 60 studies were selected. We speculated the applicability of radiogenomics and artificial intelligence through the application of machine learning algorithms to identify CHD and characterize atherosclerotic lesions and myocardial abnormalities. Radiomic features extracted by cardiac computed tomography angiography and cardiac magnetic resonance showed good diagnostic accuracy for the identification of coronary plaques and myocardium structure; on the other hand, few studies exploited radiogenomics integration, thus suggesting further research efforts in this field. Cardiac computed tomography angiography resulted the most used noninvasive imaging modality for artificial intelligence applications. Several studies provided high performance for CHD diagnosis, classification, and prognostic assessment even though several efforts are still needed to validate and standardize algorithms for CHD patient routine according to good medical practice.

Entities:  

Keywords:  artificial intelligence; biomarkers; cardiac magnetic resonance; computed tomography angiography; coronary heart disease

Mesh:

Year:  2021        PMID: 34915726     DOI: 10.1161/CIRCIMAGING.121.013025

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  4 in total

Review 1.  What Genetics Can Do for Oncological Imaging: A Systematic Review of the Genetic Validation Data Used in Radiomics Studies.

Authors:  Rebeca Mirón Mombiela; Anne Rix Arildskov; Frederik Jager Bruun; Lotte Harries Hasselbalch; Kristine Bærentz Holst; Sine Hvid Rasmussen; Consuelo Borrás
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

Review 2.  Big Data in Cardiology: State-of-Art and Future Prospects.

Authors:  Haijiang Dai; Arwa Younis; Jude Dzevela Kong; Luca Puce; Georges Jabbour; Hong Yuan; Nicola Luigi Bragazzi
Journal:  Front Cardiovasc Med       Date:  2022-04-01

3.  Multi-Slice Computed Tomography Analysis in Patients Undergoing Transcatheter Aortic Valve Replacement - Impact of Workflows on Measurement of Virtual Aortic Annulus and Valve Size.

Authors:  Kerstin Piayda; Katharina Hellhammer; Verena Veulemans; Shazia Afzal; Kathrin Klein; Nora Berisha; Pia Leuders; Ralf Erkens; Julian Kirchner; Houtan Heidari; Malte Kelm; Gerald Antoch; Tobias Zeus; Christine Quast
Journal:  Front Cardiovasc Med       Date:  2022-06-21

4.  The association of coronary non-calcified plaque loading based on coronary computed tomography angiogram and adverse cardiovascular events in patients with unstable coronary heart disease-a retrospective cohort study.

Authors:  Tianhong Yi; Suqun Huang; Daimin Li; Yao She; Ke Tan; Yi Wang
Journal:  J Thorac Dis       Date:  2022-09       Impact factor: 3.005

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.